LPS-based conjugate vaccines composed of O-polysaccharide from Pseudomonas aeruginosa IATS 6 and 11 bound to a carrier protein

被引:0
作者
Munir Al-Zeer
Hussein Masoud
机构
[1] University of Jordan,Department of Biological Sciences, Faculty of Science
来源
World Journal of Microbiology and Biotechnology | 2007年 / 23卷
关键词
Adjuvant; Conjugate vaccine; ELISA; Lipopolysaccharide;
D O I
暂无
中图分类号
学科分类号
摘要
Lipopolysaccharide (LPS) is the major surface antigen of Pseudomonas aeruginosa and elicits protective antibodies in animals. No cross reaction was observed between LPSs of P. aeruginosa International Antigenic Typing Scheme (IATS) 6 and 11 strains using rabbit polyclonal antibodies raised against the whole cells. The O-polysaccharides (O-PSs) from IATS 6 and 11, the antigenic determinant of LPS, were directly coupled to bovine serum albumin (BSA) by carbodiimide mediated condensation reaction. The molar ratios of saccharide repeating units to BSA in the prepared conjugates were 15:1 and 26:1 for IATS 6 and 11 conjugates, respectively. Mice were immunized with the conjugates emulsified with monophosphoryl lipid A (MPL), Freund, and Alum adjuvants. The conjugates emulsified with MPL adjuvant elicited the highest IgM antibody, followed by Freund. While both MPL and Freund adjuvants elicited high IgG antibody. Good correlation was observed between the IgG and IgM levels with the bactericidal activities of the sera against homologous strains. In addition, immunization of mice with the prepared conjugates emulsified with MPL and Freund adjuvants provided high protection against ten times the LD50 of P. aeruginsoa IATS 6 and 11, which showed a good correlations with the IgG titer.
引用
收藏
页码:1541 / 1549
页数:8
相关论文
共 248 条
[1]  
Bjornson AB(1971)Contribution of humoral and cellular factors to the resistance to experimental infection by Infect Immun 4 462-467
[2]  
Michael JG(1983) in mice. I. interaction between immunoglobulins, heat-labile serum factors, and phagocytic cells in the killing of bacteria Rev Infect Dis 5 279-313
[3]  
Bodey G(2001)Infections caused by Infect Immun 69 3488-3493
[4]  
Bolivar R(1991)Preparation, immunogenicity, and protective efficacy in a murine model of a conjugate vaccine composed of the polysaccharide mioety of the LPS of Infect Immun 59 4450-4458
[5]  
Fainstein V(1983) O-139 bound to tetanus toxiod Rev Infect Dis 5 S837-S845
[6]  
Jadeja L(1983)Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Infect Immun 39 1072-1079
[7]  
Bountonnier A(1984) type 1 (shiga’s bacillus) bound to tetanus toxoid Infect Immun 43 795-799
[8]  
Villeneure S(1986)Nosocomial infections due to Infect Immun 52 161-165
[9]  
Nato F(1986): review of recent trends J Infect Dis 154 682-688
[10]  
Dassy B(1987)Protection against J Clin Invest 80 51-56